Co‐operative epigenetic remodelling by Setd2 deficiency and Kras mutation drives juvenile myelomonocytic leukaemia development and MEK inhibitor sensitivity

Documenti analoghi

• Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia
  di: Julia A. Meyer, et al.
  Pubblicazione: (2025)
• Chronic myelomonocytic leukaemia
  di: Ayalew Tefferi, et al.
  Pubblicazione: (2025)
• Haematoidin in chronic myelomonocytic leukaemia during irregular treatment with hydroxycarbamide
  di: Xiaohui Zhang, et al.
  Pubblicazione: (2024)
• Peripheral blood profiling of azacitidine's hypomethylation: Advancing precision medicine in juvenile chronic myelomonocytic leukaemia
  di: Pasquale Niscola
  Pubblicazione: (2025)
• Comorbidities and mutations including single‐ and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population‐based study
  di: Matilda Kjellander Kynning, et al.
  Pubblicazione: (2025)